Skip to content
stockresearch.app
VRTX/History

Vertex Pharmaceuticals (VRTX) valuation history

Above its usual range

As of

VRTX's P/E of 30.6x is higher than 79% of its available weekly readings from the last five years.

P/E weekly history20.4×25.9×31.4×36.9×Shading: 5-year middle halfMedian 28.2×30.6×202120232025
Share P/E history
Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

P/E at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

VRTX year-end valuation history
Reading dateP/E5-year rank
31.8×94%
UnavailableShort history
30.6×82%
22.8×27%
26.4×40%
23.1×21%
26.4×29%
69.1×7%
192.1×90%
UnavailableShort history

Loading related research…

About this history

What is VRTX's current P/E?
VRTX's P/E of 30.6x is higher than 79% of its available weekly readings from the last five years.
What is VRTX's five-year median P/E?
The median, or middle weekly reading, is 28.2× over the last five years. Available history contains 818 weekly observations from Feb 21, 2011 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Source: SEC company filings and weekly market prices. Multiples use the previous twelve months of financial results. Updated .

Read the valuation methodology